For example, in studies conducted in patients suffering from AD, PD, and schizophrenia, the ROS-induced hypermethylation of the Nrf2 promoter resulted in decreased levels of expression of detoxifying enzymes, such as sod, catalase, and glutathione-S-transferase. This evidence concerns the gene CAT and Parkinson disease.